Document Detail

New perspectives for use of native and engineered recombinant food proteins in treatment of food allergy.
MedLine Citation:
PMID:  17276882     Owner:  NLM     Status:  MEDLINE    
Food allergy has emerged as an important target for research on curative treatment and prevention, with most efforts focusing on peanut, cow's milk, and egg allergy. This article reviews the recent developments in the potential treatments for IgE-mediated food allergy using native and engineered recombinant food proteins.
Anna Nowak-Wegrzyn
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Immunology and allergy clinics of North America     Volume:  27     ISSN:  0889-8561     ISO Abbreviation:  Immunol Allergy Clin North Am     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-05     Completed Date:  2007-06-01     Revised Date:  2013-06-06    
Medline Journal Info:
Nlm Unique ID:  8805635     Medline TA:  Immunol Allergy Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  105-27     Citation Subset:  IM    
Jaffe Food Allergy Institute, Division of Allergy and Immunology, Department of Pediatrics, Mount Sinai School of Medicine, Box 1198, One G. Levy Place, NY 10029, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Food Hypersensitivity / diet therapy*,  immunology
Food, Genetically Modified*
Middle Aged
Recombinant Proteins*
Grant Support
K23 AI 059318/AI/NIAID NIH HHS; K23 AI059318-02/AI/NIAID NIH HHS
Reg. No./Substance:
0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy.
Next Document:  A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit...